Evolving With The Clinical Development Landscape
Now in it's 19th year, Clinical Trials Europe develops with the industry, keeping on-top of the latest innovations to provide you with the most valuable content and connections to take pharma and biotech patient solutions to new levels. And this year, you can access the event from all over the globe.
Over the past 18 years, Clinical Trials Europe (CTE), previously known as Partnerships in Clinical Trials (PCT) Europe, has transformed with the industry, providing a meeting place for all of the key stakeholders to participate in cutting edge discussion, hear from a wealth of leading stakeholder perspectives and connect through unique networking opportunities.
In this considerable period of time, we have seen a major shift from 'partnerships' in clinical trials being perceived purely as a CRO-sponsor relationship, to incorporating everyone from patients, patient groups, associations and academic institutions right through to regulators, technology innovators, consultants and more.
As Europe's largest event dedicated to streamlining clinical trials and improving the lives of patients, we exist to connect all of these key stakeholder groups together and provide a vital platform for learning, networking and collaboration, helping you to stay on the pulse, and to discover what you need to drive efficiencies and discover new therapies.
This continued change is the backbone of Clinical Trials Europe where, Informa Connect Life Sciences, in collaboration with and a diverse panel of senior level experts from across the industry, have worked together to produce a content-focused and structured event, where all of the key elements from Partnerships & Outsourcing, Operations and Technology & AI are exposed in great detail.
Over the course of three days of stimulating discourse across six focused conference streams, featuring; two plenary keynote sessions; the annual lifetime achievement award in association with mdgroup; an inspirational talk; ever-popular interactive panel discussions; and evening networking receptions; Clinical Trials Europe offers the opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, patient groups, academic research centres and beyond, to come together to share best practices and discuss the new era of technology and patient-centric trials.
During a period of five months of research we spoke to over a 100 people from across the industry to identify the most important areas of change and innovation in order to incorporate the hottest topics into the agenda based on popular demand.
Now being delivered as a 100% virtual conference and exhibition to provide everyone the opportunity to access this well established meeting of industry thought leaders, this year's meeting will address the latest developments surrounding the global pandemic, as well as strategic updates and practical advice for accelerating clinical development through partnerships, outsourcing, operations and technology.
View the full Clinical Trials Europe Virtual conference agenda to find out more about why Clinical Trials Europe is 19 years strong...